Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options.
Amrolia
Persis J
PJ
Department of Bone Marrow Transplantation, Great Ormond Street Hospital for Sick Children, London, UK. amrolp1@gosh.nhs.uk
Almeida
Antonio
A
Halsey
Christina
C
Roberts
Irene A G
IA
Davies
Sally C
SC
D000755:Anemia, Sickle Cell / Q000628:therapy*; D000986:Antisickling Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000379:methods; D015815:Cell Adhesion Molecules / Q000037:antagonists & inhibitors; D002648:Child; D002986:Clinical Trials as Topic; D017707:Erythrocyte Transfusion / Q000379:methods; D005232:Fatty Acids, Volatile / Q000627:therapeutic use; D005312:Fetal Blood / Q000637:transplantation; D015316:Genetic Therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D018579:Patient Selection; D033581:Stem Cell Transplantation / Q000379:methods
D000986:Antisickling Agents; D015815:Cell Adhesion Molecules; D005232:Fatty Acids, Volatile; D006918:Hydroxyurea